DUBAI/WAM Polynome Group announceD the launch of The AI Academy, an AI-focused educational initiative in ...
Read More »FDA staff raises concerns over lack of safety data for sickle-cell treatment
BLOOMBERG The Food and Drug Administration’s (FDA) staff raised concerns about safety data on a potential gene-editing treatment for sickle cell disease, ahead of a closely watched meeting where scientific experts will weigh the first therapy using Crispr technology. FDA advisers are preparing to meet on October 31 to consider and discuss an application from Vertex Pharmaceuticals Inc and Crispr ...
Read More »